MAPT and Alzheimer disease: Interestingly, DAPA-induced mitigation of BACE1 and p-Tau was counteracted by AMPK or SIRT1 inhibition, indicating AMPK/SIRT1 signaling involvement in DAPA’s neuroprotective effect against AD-associated anomalies.